NF-κB targets miR-16 and miR-21 in gastric cancer: Involvement of prostaglandin E receptors

Carcinogenesis

Volumn 32, Issue 2, 2011, Pages 240-245

  Shin, Vivian Y ^a   Jin, Hongchuan ^b   Ng, Enders K O ^a   Cheng, Alfred S L ^c,d   Chong, Wilson W S ^c,d   Wong, Christine Y P ^c,d   Leung, Wai K ^c,d   Sung, Joseph J Y ^c,d   Chu, Kent Man ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY   (China)

^c LKS Institute of Health Sciences   (China)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BAY 117085; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 16; MICRORNA 21; NICOTINE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E4 RECEPTOR; PROTEIN INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

EID: 79251584345     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq240     Document Type: Article

References (36)

1. Kelley,J.R. et al. (2003) Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol., 56, 1-9.
2. Ladeiras-Lopes,R. et al. (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control, 19, 689-701.
3. Heeschen,C. et al. (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med., 7, 833-839.
4. Dasgupta,P. et al. (2006) Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc. Natl Acad. Sci. USA, 103, 6332-6337.
5. Arredondo,J. et al. (2006) Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J., 20, 2093-2101.
6. Shin,V.Y. et al. (2007) Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol. Sci., 96, 21-29.
7. Shin,V.Y. et al. (2008) Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: involvement of nicotinic acetylcholine receptor (nAChR) and betaadrenergic receptor signaling pathways. Toxicol. Appl. Pharmacol., 233, 254-261.
8. Shin,V.Y. et al. (2005) Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol. Cancer Res., 3, 607-615.
9. Shin,V.Y. et al. (2004) Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis, 25, 2487-2495.
10. Shin,V.Y. et al. (2010) Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth. Cancer Lett., 292, 237-245.
11. Calin,G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
12. He,L. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
13. Lee,Y.S. et al. (2009)MicroRNAs in cancer. Annu. Rev. Pathol., 4, 199-277.
14. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
15. Ueda,T. et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 11, 136-146.
16. Schembri,F. et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl Acad. Sci. USA, 106, 2319-2324.
17. Ng,E.K. et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-1381.
18. Lee,T.I. et al. (2006) Chromatin immunoprecipitation and microarraybased analysis of protein location. Nat. Protoc., 1, 729-748.
19. Cheng,A.S. et al. (2006) Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol. Cell, 21, 393-404.
20. Carthew,R.W. et al. (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell, 136, 642-655.
21. Ghildiyal,M. et al. (2009) Small silencing RNAs: an expanding universe. Nat. Rev. Genet., 10, 94-108.
22. Croce,C.M. et al. (2005) miRNAs, cancer, and stem cell division. Cell, 122, 6-7.
23. Ma,L. et al. (2008) Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet., 24, 448-456.
24. Esquela-Kerscher,A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
25. Huang,W. et al. (2009) Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int. J. Neuropsychopharmacol., 12, 537-546.
26. Si,M.L. et al. (2007) miR-21-mediated tumor growth. Oncogene, 26, 2799-2803.
27. Zhang,Z. et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest., 88, 1358-1366.
28. Loayza-Puch,F. et al. (2010) Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene, 29, 2638-2648.
29. Bonci,D. et al. (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med., 14, 1271-1277.
30. Suzuki,H.I. et al. (2009) Modulation of microRNA processing by p53. Nature, 460, 529-533.
31. Wang,X. et al. (2009) MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. Biochem. Biophys. Res. Commun., 387, 376-380.
32. Karin,M. (2006) Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-436.
33. Yang,C.M. et al. (2009) Cigarette smoke extract induces COX-2 expression via a PKCalpha/c-Src/EGFR, PDGFR/PI3K/Akt/NF-kappaB pathway and p300 in tracheal smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 297, L892-L902.
34. Hawcroft,G. et al. (2007) Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene, 26, 3006-3019.
35. Banu,S.K. et al. (2009) Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol. Endocrinol., 23, 1291-1305.
36. Iwamoto,J. et al. (2008) The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells. Helicobacter, 13, 174-182.